Go

Breaking News on Drug Discovery

All feeds

All news articles > All Weekly comments

Paediatric drugs and testing highlighted

26-Nov-2007 - The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego.

No embryo required: human stem cells from the skin

21-Nov-2007 - A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma.

South Africa 'underutilised' for clinical trials

20-Nov-2007 - While India, the Asia-Pacific, Eastern Europe and Latin America are all gaining recognition as potential new hot spots, South Africa remains 'underutilised as a clinical trial destination,' according to a prominent industry figure.

Pharma must 'reinvent' itself to survive

02-Nov-2007 - With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent themselves will need to move on apace in order to secure their position in a changing market.

Big pharma lends a helping hand

29-Oct-2007 - Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis.

Pfizer partners in shock after surprise Exubera exit

22-Oct-2007 - We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find out the product was being scrapped through a press release.

Pharmaceuticals is top R&D spender

08-Oct-2007 - As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development.

FDA told its safety monitoring of clinical trials not good enough

02-Oct-2007 - The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials.

Cheap drugs, no profit, just cures

17-Sep-2007 - A group of leading drug developers have set up an international talent network for a 'global assault' on some of the world's deadliest diseases, such as tuberculosis (TB), malaria and AIDS, on a not-for-profit basis.

UK gets go-ahead for hybrid embryo research

06-Sep-2007 - Eight months after the debate started over whether hybrid embryo research should be allowed in the UK, the Human Fertilisation and Embryology Authority (HFEA) has given researchers the thumbs up - but only on a case-by-case basis.

Chinese scientists given freedom to fail

30-Aug-2007 - As part of a drive towards greater innovation, the Chinese government looks set to introduce new laws giving its domestic scientists freedom to tackle complex scientific problems without fear of failure, according to a state media report this week.

UK tightens Phase I guidelines

21-Aug-2007 - The Association of the British Pharmaceutical Industry (ABPI) has now published revised guidelines for Phase I trials in the UK.

No lack of innovation in pharma, says Wyeth

14-Aug-2007 - The often cited decline in R&D productivity and dwindling innovation within the pharma industry is actually a thing of the past, according to Wyeth's head of business development.

Speculation on gene therapy trial death 'premature'

08-Aug-2007 - Targeted Genetics said it was 'premature as well as irresponsible' to draw any conclusions on what caused the death of a patient who participated in a clinical trial testing the safety of the firm's new gene therapy.

UK ordered to review animal testing approval system

30-Jul-2007 - The UK government has been ordered to review the assessment system it uses to classify and grant permission for animal experiments following a court ruling handed down last week.

Informed consent 'not up to scratch'

18-Jul-2007 - A recent survey of clinical trial participants in the US has revealed worrying signs that the informed consent process is 'not up to scratch'.

China carries out execution on corrupt drug official

10-Jul-2007 - China has wasted no time in executing the first of its convicted corrupt former drug officials after his desperate appeal for life failed.

Corrupt Chinese drug official appeals death penalty

13-Jun-2007 - The former director of the country's State Food and Drug Administration (SFDA) has lodged an appeal against the death penalty slapped on him after a corruption conviction.

Vioxx scandal points to deeper industry issues

24-Aug-2005 - Vioxx. Bextra. Zyprexa, Seroxat. At no period of time have so many high-profile drugs come under the spotlight as drug companies face legal action over drug safety. It's make or break time for the pharmaceutical industry as drug companies are possibly facing its biggest crisis since the thalidomide fiasco almost fifty years ago.